Skip to main content
. 2019 Dec 5;9:18417. doi: 10.1038/s41598-019-55044-7

Figure 4.

Figure 4

The cytotoxic activity of recombinant javanicin against MCF-7 and MDA-MB-231 cell lines. Various concentrations of recombinant javanicin were examined for determination of anti-proliferative activity against human breast cancer cell lines, MCF-7 & MDA-MB-231. The 50% growth inhibitory concentration (IC50) of peptide to each immortalized cell was calculated. The experiment was done in thrice. Error bars indicated standard deviations.